| # | Drug | Count |
|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 745 |
| 1 | ADALIMUMAB | 593 |
| 2 | BEVACIZUMAB | 527 |
| 3 | DEXAMETHASONE | 496 |
| 4 | DEXAMETHASONE 1.5 MG | 494 |
| 5 | FUROSEMIDE | 467 |
| 6 | PREDNISONE | 441 |
| 7 | OMEPRAZOLE MAGNESIUM | 432 |
| 8 | PANTOPRAZOLE | 419 |
| 9 | ASPIRIN | 413 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-PHENYLALANINE | 12 | 0.1519 |
| 1 | L DOPA | 15 | 0.0560 |
| 2 | NEOSTIGMINE METHYLSULFATE | 13 | 0.0302 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 134 | 0.0160 |
| 4 | BODY CLEANSER | 10 | 0.0140 |
| 5 | METHYLENE BLUE | 22 | 0.0139 |
| 6 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | 41 | 0.0128 |
| 7 | HYDROCORTISONE VALERATE | 8 | 0.0127 |
| 8 | MIGLITOL | 12 | 0.0125 |
| 9 | ZIV-AFLIBERCEPT | 15 | 0.0115 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1502 |
| 1 | GLP-1 Receptor Agonist [EPC] | 1112 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1035 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 912 |
| 4 | Platinum-based Drug [EPC] | 881 |
| 5 | Benzodiazepine [EPC] | 685 |
| 6 | Atypical Antipsychotic [EPC] | 663 |
| 7 | Proton Pump Inhibitor [EPC] | 603 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 561 |
| 9 | Osmotic Laxative [EPC] | 546 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 1 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 16 | 0.0105 |
| 2 | Vasoconstrictor [EPC] | 3 | 0.0100 |
| 3 | Actinomycin [EPC] | 15 | 0.0068 |
| 4 | Complement Factor D Inhibitor [EPC] | 2 | 0.0065 |
| 5 | Chloride Channel Activator [EPC] | 61 | 0.0064 |
| 6 | Antihypoglycemic Agent [EPC] | 27 | 0.0063 |
| 7 | Tricyclic Antidepressant [EPC] | 3 | 0.0063 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 244 | 0.0052 |
| 9 | Macrolide Antibacterial [EPC] | 5 | 0.0049 |